Obesity adversely impacts disease specific outcomes in patients with upper tract urothelial carcinoma

Journal of Urology

Volumn 186, Issue 1, 2011, Pages 66-72

  Ehdaie, Behfar ^b   Chromecki, Thomas F ^a,c   Lee, Richard K ^a   Lotan, Yair ^d   Margulis, Vitaly ^d   Karakiewicz, Pierre I ^e   Novara, Giacomo ^f   Raman, Jay D ^g   Ng, Casey ^a,h   Lowrance, William T ^a,i   Scherr, Douglas S ^b   Shariat, Shahrokh F ^b,j  

^a Department of Urology ^*  (United States)

^b WEILL CORNELL MEDICAL CENTER   (United States)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

^d UNIVERSITY OF TEXAS AT DALLAS   (United States)

^e UNIVERSITÉ DE MONTRÉAL   (Canada)

^f UNIVERSITY OF PADOVA   (Italy)

^g PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^h UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

ⁱ UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^j WEILL CORNELL MEDICAL COLLEGE   (United States)

more..

Author keywords

body mass index; carcinoma; obesity; urinary tract; urothelium

Indexed keywords

ADVERSE OUTCOME; ARTICLE; BODY MASS; CANCER INVASION; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; HUMAN; MAJOR CLINICAL STUDY; NEPHROURETERECTOMY; OBESITY; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RADICAL NEPHROURETERECTOMY; RETROSPECTIVE STUDY; TRANSITIONAL CELL CARCINOMA; TREATMENT OUTCOME; UNIVARIATE ANALYSIS; UPPER TRACT UROTHELIAL CARCINOMA;

BODY MASS INDEX; CARCINOMA, TRANSITIONAL CELL; HUMANS; KIDNEY NEOPLASMS; OBESITY; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; URETERAL NEOPLASMS;

EID: 79958245079     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2011.03.031     Document Type: Article

References (29)

1. P. Deurenberg, J.A. Weststrate, and J.C. Seidell Body mass index as a measure of body fatness: age- and sex-specific prediction formulas Br J Nutr 65 1991 105
2. Physical status: the use and interpretation of anthropometry Report of a WHO Expert Committee World Health Organ Tech Rep Ser 854 1995 1
3. K.M. Flegal, M.D. Carroll, and C.L. Ogden Prevalence and trends in obesity among US adults, 19992000 JAMA 288 2002 1723
4. A.H. Mokdad, B.A. Bowman, and E.S. Ford The continuing epidemics of obesity and diabetes in the United States JAMA 286 2001 1195
5. Obesity: preventing and managing the global epidemic Report of a WHO consultation World Health Organ Tech Rep Ser 894 2000 i
6. G.D. Batty, M.J. Shipley, and R.J. Jarrett Obesity and overweight in relation to organ-specific cancer mortality in London (UK): findings from the original Whitehall study Int J Obes (Lond) 29 2005 1267
7. E.E. Calle, C. Rodriguez, and K. Walker-Thurmond Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults N Engl J Med 348 2003 1625
8. H. Møller, A. Mellemgaard, and K. Lindvig Obesity and cancer risk: a Danish record-linkage study Eur J Cancer 30A 1994 344
9. S.Y. Pan, K.C. Johnson, and A.M. Ugnat Association of obesity and cancer risk in Canada Am J Epidemiol 159 2004 259
10. K. Rapp, J. Schroeder, and J. Klenk Obesity and incidence of cancer: a large cohort study of over 145,000 adults in Austria Br J Cancer 93 2005 1062
11. C. Samanic, G. Gridley, and W.H. Chow Obesity and cancer risk among white and black United States veterans Cancer Causes Control 15 2004 35
12. A. Wolk, G. Gridley, and M. Svensson A prospective study of obesity and cancer risk (Sweden) Cancer Causes Control 12 2001 13
13. W.T. Lowrance, R.H. Thompson, and D.S. Yee Obesity is associated with a higher risk of clear-cell renal cell carcinoma than with other histologies BJU Int 105 2010 16
14. E.M. Siegel, C.M. Ulrich, and E.M. Poole The effects of obesity and obesity-related conditions on colorectal cancer prognosis Cancer Control 17 2010 52
15. S.J. Freedland, L. Sun, and C.J. Kane Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases BJU Int 102 2008 969
16. L. Dal Maso, A. Zucchetto, and R. Talamini Effect of obesity and other lifestyle factors on mortality in women with breast cancer Int J Cancer 123 2008 2188
17. A.S. Parker, C.M. Lohse, and J.C. Cheville Greater body mass index is associated with better pathologic features and improved outcome among patients treated surgically for clear cell renal cell carcinoma Urology 68 2006 741
18. S. Waalkes, A.S. Merseburger, and M.W. Kramer Obesity is associated with improved survival in patients with organ-confined clear-cell kidney cancer Cancer Causes Control 21 2010 1905
19. C.N. Holick, E.L. Giovannucci, and M.J. Stampfer Prospective study of body mass index, height, physical activity and incidence of bladder cancer in US men and women Int J Cancer 120 2007 140
20. C. Koebnick, D. Michaud, and S.C. Moore Body mass index, physical activity, and bladder cancer in a large prospective study Cancer Epidemiol Biomarkers Prev 17 2008 1214
21. J. Hafron, N. Mitra, and G. Dalbagni Does body mass index affect survival of patients undergoing radical or partial cystectomy for bladder cancer? J Urol 173 2005 1513
22. A. Jemal, R. Siegel, and E. Ward Cancer statistics, 2007 CA Cancer J Clin 57 2007 43
23. V. Margulis, S.F. Shariat, and S.F. Matin Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration Cancer 115 2009 1224
24. G. Lughezzani, C. Jeldres, and H. Isbarn Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients Eur J Cancer 45 2009 3291
25. A.M. Suikkari, V.A. Koivisto, and E.M. Rutanen Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein J Clin Endocrinol Metab 66 1988 266
26. M. Iwamura, M. Ishibe, and P.M. Sluss Characterization of insulin-like growth factor I binding sites in human bladder cancer cell lines Urol Res 21 1993 27
27. S.F. Shariat, J. Kim, and C. Nguyen Correlation of preoperative levels of IGF-I and IGFBP-3 with pathologic parameters and clinical outcome in patients with bladder cancer Urology 61 2003 359
28. M. Hilmy, J.M. Bartlett, and M.A. Underwood The relationship between the systemic inflammatory response and survival in patients with transitional cell carcinoma of the urinary bladder Br J Cancer 92 2005 625
29. B. Andrews, S.F. Shariat, and J.H. Kim Preoperative plasma levels of interleukin-6 and its soluble receptor predict disease recurrence and survival of patients with bladder cancer J Urol 167 2002 1475